Enodia Therapeutics
Develops small-molecule therapies for targeted protein degradation at the point of synthesis
€20.7MSeed
Role not disclosedLoading investors…
Activity from announced rounds
Develops small-molecule therapies for targeted protein degradation at the point of synthesis
Develops novel bispecific antibodies for targeted degradation of extracellular proteins in oncolo...
Pitching Mission BioCapital? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room